DEA’s final rescheduling brief argues marijuana can no longer remain in Schedule I. What could Schedule III mean for cannabis M&A, valuations, cash flow, distressed assets and strategic buyers?

Federal cannabis reform is moving through both administrative and legislative channels. Whether marijuana is rescheduled or ultimately legalized, cannabis businesses should understand how these changes could affect valuations, mergers and acquisitions, capital formation, and long-term strategy.